BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
biote Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$1.08−0.00 (-0.46%)
Close on Oct 19, 2026
- Market cap
- $30.92M
- P/E (TTM)
- 10.8
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$121.50M
$3.13M due within a year
Net debt
$110.33M
After $11.17M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in biote's annual report. Trading prices and yields need FINRA TRACE data.